Elongation factor 2 in cancer: a promising therapeutic target in protein translation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Elongation factor 2 in cancer: a promising therapeutic target in protein translation ; volume:29 ; number:1 ; day:20 ; month:12 ; year:2024 ; pages:1-21 ; date:12.2024
Cellular & molecular biology letters ; 29, Heft 1 (20.12.2024), 1-21, 12.2024
- Creator
-
Jia, Xuechao
Huang, Chuntian
Liu, Fangfang
Dong, Zigang
Liu, Kangdong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s11658-024-00674-7
- URN
-
urn:nbn:de:101:1-2503012107532.213228939488
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jia, Xuechao
- Huang, Chuntian
- Liu, Fangfang
- Dong, Zigang
- Liu, Kangdong
- SpringerLink (Online service)
Other Objects (12)
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
Eukaryotic translation initiation factors as promising targets in cancer therapy
Structural analysis of eukaryotic translation elongation
Metabolism of Polyamines and Kidney Disease: A Promising Therapeutic Target
The Plasmodium falciparum cytoplasmic translation apparatus: a promising therapeutic target not yet exploited by clinically approved anti-malarials
The HIV-1 gag p6: a promising target for therapeutic intervention
Function of Elongation Factor P in Translation
The translation elongation factor P in actinobacteria
Mitochondrial respiratory chain component NDUFA4: a promising therapeutic target for gastrointestinal cancer
Periodontal ligament stem cells as a promising therapeutic target for neural damage
Sclerostin is a promising therapeutic target for oral inflammation and regenerative dentistry
A Promising Therapeutic Target for Metabolic Diseases: Neuropeptide Y Receptors in Humans
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
Eukaryotic translation initiation factors as promising targets in cancer therapy
Structural analysis of eukaryotic translation elongation
Metabolism of Polyamines and Kidney Disease: A Promising Therapeutic Target
The Plasmodium falciparum cytoplasmic translation apparatus: a promising therapeutic target not yet exploited by clinically approved anti-malarials
The HIV-1 gag p6: a promising target for therapeutic intervention
Function of Elongation Factor P in Translation
The translation elongation factor P in actinobacteria
Mitochondrial respiratory chain component NDUFA4: a promising therapeutic target for gastrointestinal cancer
Periodontal ligament stem cells as a promising therapeutic target for neural damage
Sclerostin is a promising therapeutic target for oral inflammation and regenerative dentistry
A Promising Therapeutic Target for Metabolic Diseases: Neuropeptide Y Receptors in Humans
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
Eukaryotic translation initiation factors as promising targets in cancer therapy
Structural analysis of eukaryotic translation elongation
Metabolism of Polyamines and Kidney Disease: A Promising Therapeutic Target
The Plasmodium falciparum cytoplasmic translation apparatus: a promising therapeutic target not yet exploited by clinically approved anti-malarials
The HIV-1 gag p6: a promising target for therapeutic intervention
Function of Elongation Factor P in Translation
The translation elongation factor P in actinobacteria
Mitochondrial respiratory chain component NDUFA4: a promising therapeutic target for gastrointestinal cancer
Periodontal ligament stem cells as a promising therapeutic target for neural damage
Sclerostin is a promising therapeutic target for oral inflammation and regenerative dentistry